Mandated Use of Prescription Drug Monitoring Programs (PMPs) Map Research Current as of January 2, 2018. This project was supported by Grant No. G1799ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions in this document are those of the author and do not necessarily represent the official position or policies of the Office of National Drug Control Policy or the United States Government. 2018 National Alliance for Model State Drug Laws (NAMSDL). Research is current as of January 2, 2018. Research is conducted using both nationwide legal database software and individual state legislative/regulatory websites. This document may be reproduced in whole or in part for non-commercial purposes with full attribution to NAMSDL. This document and the information therein is for educational purposes only and does not constitute legal advice or opinion. Please contact Chad Zadrazil at czadrazil@namsdl.org or at 703-584-7043 with any additional updates or information that may be relevant to this map. For more information about NAMSDL, please go to www.namsdl.org
Mandated Use of PMPs 37 States with Specified Circumstances Requiring Prescriber Access* WA NH CA OR NV ID AZ UT MT WY CO NM ND SD NE KS OK MN IA MO AR WI IL MI IN KY TN OH VT NY PA WV VA NC SC ME DE MD RI CT NJ MA DC (no mandate) MS AL GA TX AK LA FL HI * Exceptions may apply and effective dates may vary. Preparation for implementation may result in a time difference between the enactment and effective date(s) and date of For more information about mandated use of PMPs, please see Mandated Use of Prescription Drug Monitoring Programs (PMPs) Highlights of Key State Requirements, www.namsdl.org 2018 The National Alliance for Model State Drug Laws (NAMSDL).
AK SB 74 (2016) Eff. as of 7/17/17 AR SB 339 (2017) Additional mandate eff. 90 days after adjournment AZ SB 1283 (2016) Additional mandate eff. on 10/1/17 or 60 days after state HIE integrates PMP data, whichever is later CA SB 483 (2016) Eff. 6 months after certification that PMP ready for statewide use and DOJ has adequate staff, user support, and education CT HB 5053 Modified eff. 7/1/16 GA HB 249 (2017) Additional mandate eff. as of 7/1/18 AND if Department of Health certifies PMP accessible and operational 99.5% of time IL SB 772 (2017) Eff. 1/1/18 IN SEA 297 (2016) Additional mandate section eff. 7/1/16 LA SB 55 (2017) Modified mandate eff. on Governor s signature ME LD 1646 (2016) Eff. on or after 1/1/17
MD HB 437 (2016) Eff. on 7/1/18 and contingent on Secretary of Health and Mental Hygiene s determination PMP technical capable of such access MA HB 4056 (2016) Additional mandate section eff. 10/15/16 NV SB 59 (2017) Modified mandate eff. 7/1/17 NH SB 576-FN-A (2016) Eff. 9/1/16 if moneys appropriated or otherwise acquired for technology upgrades to PMP NH HB 291 (2017) Modified mandate eff. 60 days after passage NM SB 263 (2016) Additional mandate eff. 1/1/17 NC HB 243 (2017) Applies to acts committed 30 days after CIO notifies Revisor of Statutes that (1) PMP upgrades completed, and (2) upgraded database fully operational within Dept. of Information Technology and is connected to state HIE PA SB 1202 (2016) Additional mandate eff. 60 days after passage
RI SB 2823A Amended (2016) Additional mandate eff. upon passage SC HB 3824 (2017) Additional mandate eff. upon Governor s approval TX HB 2561 (2017) Eff. 9/1/19 UT HB 375 (2016) Eff. 60 days after adjournment UT HB 50 (2017) Modified mandate eff. 60 days after adjournment VA HB 293 (2016) Modified mandate eff. 7/1/16 VA SB 1180 (2017) Eff. on passage VA SB 1232 (2017) Modified mandate eff. 7/1/17 WI AB 364 (2016) Eff. 4/1/17 WV SB 454 (2016) Additional mandate eff. 90 days from passage